left ventricular hypertrophy is considered a fairly marginal risk on low dose oral minoxidil, but personally I got a baseline ECG and follow-ups every 2 years since starting. Ignoring extremely early adopters, we’re at 5 years since it exploded in popularity.
In another 5 there will have been so many people on it that the rarity question could be ballparked.
I think the association with fin was incredibly weak, though dutasteride seems to be more of an open question. Have you tried a protocol where you take dut 2 times a week and fin the rest? Switching back and forth might not be best.
Many see it as worth a shot. I know the current gray market PP405s are “fake”, but according to the patents they exhibited the same MPC inhibition mechanism. So if the real one works, I’d expect the more advanced attempts from gray market to do something in some people given the popularity. We’ll see.
There’s also topical dutasteride options if you’re worried about systemic effects. Most are bunk that are dosed so high they will anyway, but Xyon is probably the most popular.
Another recent contender is Anagen Precision Dutasteride, but it’s pricey and I’d wait until the human study they’re planning happens unless you like taking the risk of losing your hair https://anagen.xyz/products/precision-dutasteride. Full disclosure I think their HairDAO project is really cool, but no conflicts beyond liking them.
I’m at the point where hair loss stuff is so astroturfed I don’t trust any anecdotes lol.
Look at what started this thread - a sketchy company took down a confirmed legitimate negative review, blamed it on their competitor anyway, then posted a variety of fake positive ones. And this was one hobbyist gray market IT worker doing it in his spare time - what could a real business do to trick us?